Literature DB >> 1403636

Detection of incident HIV infection by PCR compared to serology.

S Read1, S Cassol, R Coates, C Major, B McLaughlin, T Salas, A Francis, M Fanning, D MacFadden, F Shepherd.   

Abstract

In order to determine the most sensitive method for the early detection of HIV infection, polymerase chain reaction (PCR) and serology were compared using matched peripheral blood mononuclear cells (PBMC) and serum samples taken sequentially at 3-month intervals on 17 HIV seroconverters. All samples from the time of enrollment in the study to the time of seroconversion were studied. [There were only two of the 17 cases where PCR and antigen positivity preceded EIA detectable seroconversion.] Initially, one of these cases was found to be PCR positive 11 months prior to seroconversion, however DNA fingerprinting techniques indicated that the early positive specimen did not belong to the subject in question. In a single subject, PCR was negative at the time of serologic evidence of infection but was positive at the next sampling 3 months later. In the remaining 14 cases, PCR was positive at the same sample time as full or partial seroconversion as determined by three EIA screening tests and Western blot. EIA antibody screen tests showed variability in detection of early HIV antibodies. We found no evidence for prolonged HIV infection prior to seroconversion. PCR offers little if any advantage over serology in the early detection of HIV infection in adults.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403636

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  2 in total

1.  An optimized nested polymerase chain reaction (PCR) approach allows detection and characterization of human immunodeficiency virus type 1 (HIV-1) env and gag genes from clinical samples.

Authors:  Dayse Locateli; Patricia H Stoco; Carlos R Zanetti; Aguinaldo R Pinto; Edmundo C Grisard
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

2.  Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA.

Authors:  D D Panteleeff; G John; R Nduati; D Mbori-Ngacha; B Richardson; J Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.